Annual Total Long Term Liabilities
$855.51 M
+$152.96 M+21.77%
December 31, 2023
Summary
- As of February 12, 2025, ASND annual total long term liabilities is $855.51 million, with the most recent change of +$152.96 million (+21.77%) on December 31, 2023.
- During the last 3 years, ASND annual total long term liabilities has risen by +$746.93 million (+687.92%).
- ASND annual total long term liabilities is now at all-time high.
Performance
ASND Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$393.87 M
+$145.52 M+58.59%
September 30, 2024
Summary
- As of February 12, 2025, ASND quarterly total long term liabilities is $393.87 million, with the most recent change of +$145.52 million (+58.59%) on September 30, 2024.
- Over the past year, ASND quarterly long term liabilities has dropped by -$382.95 million (-49.30%).
- ASND quarterly long term liabilities is now -53.96% below its all-time high of $855.51 million, reached on December 31, 2023.
Performance
ASND Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ASND Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.8% | -49.3% |
| 3 y3 years | +687.9% | +255.4% |
| 5 y5 years | +100.0% | +1042.7% |
ASND Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +648.6% | -54.0% | +244.7% |
| 5 y | 5-year | at high | +2314.8% | -54.0% | +1103.8% |
| alltime | all time | at high | -100.0% | -54.0% | -100.0% |
Ascendis Pharma A/S Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $393.87 M(+58.6%) |
| Jun 2024 | - | $248.35 M(-4.9%) |
| Mar 2024 | - | $261.02 M(-69.5%) |
| Dec 2023 | $855.51 M(+21.8%) | $855.51 M(+10.1%) |
| Sep 2023 | - | $776.82 M(+26.1%) |
| Jun 2023 | - | $615.86 M(-6.0%) |
| Mar 2023 | - | $655.04 M(-6.8%) |
| Dec 2022 | $702.55 M(+514.8%) | $702.55 M(+5.3%) |
| Sep 2022 | - | $667.41 M(+5.8%) |
| Jun 2022 | - | $630.79 M(-7.2%) |
| Mar 2022 | - | $679.81 M(+494.9%) |
| Dec 2021 | $114.28 M(+5.2%) | $114.28 M(+3.1%) |
| Sep 2021 | - | $110.83 M(-1.0%) |
| Jun 2021 | - | $111.93 M(+6.6%) |
| Mar 2021 | - | $105.00 M(-3.3%) |
| Dec 2020 | $108.58 M(+206.5%) | $108.58 M(+207.1%) |
| Sep 2020 | - | $35.35 M(+8.1%) |
| Jun 2020 | - | $32.72 M(-3.6%) |
| Mar 2020 | - | $33.93 M(-4.2%) |
| Dec 2019 | $35.43 M | $35.43 M(+2.8%) |
| Sep 2019 | - | $34.47 M(-3.6%) |
| Jun 2019 | - | $35.77 M(+141.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $14.84 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00 |
| Dec 2012 | $0.00(-100.0%) | - |
| Dec 2011 | $275.90 K | - |
FAQ
- What is Ascendis Pharma A/S annual total long term liabilities?
- What is the all time high annual total long term liabilities for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual total long term liabilities year-on-year change?
- What is Ascendis Pharma A/S quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly long term liabilities year-on-year change?
What is Ascendis Pharma A/S annual total long term liabilities?
The current annual total long term liabilities of ASND is $855.51 M
What is the all time high annual total long term liabilities for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual total long term liabilities is $855.51 M
What is Ascendis Pharma A/S annual total long term liabilities year-on-year change?
Over the past year, ASND annual total long term liabilities has changed by +$152.96 M (+21.77%)
What is Ascendis Pharma A/S quarterly total long term liabilities?
The current quarterly long term liabilities of ASND is $393.87 M
What is the all time high quarterly long term liabilities for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly total long term liabilities is $855.51 M
What is Ascendis Pharma A/S quarterly long term liabilities year-on-year change?
Over the past year, ASND quarterly total long term liabilities has changed by -$382.95 M (-49.30%)